Tongkat Ali Side Effects: Insomnia & Mercury Risk
Informational summary of published research and testing surveys — not medical advice. Buy only third-party-tested tongkat ali; heavy-metal contamination is a documented, real risk. Avoid in pregnancy or with a hormone-sensitive condition.
Tongkat ali's most-reported side effect is insomnia, especially at higher doses or taken late in the day; taking it in the morning helps. Restlessness and mild GI upset are reported less often. Separately, heavy-metal contamination is a real, documented problem: surveys found a meaningful share of commercial products over the mercury limit. That is a product-quality issue, not a pharmacology one. Buy only third-party-tested products, and avoid it if you are pregnant or have a hormone-sensitive condition.
Looking for a tested product, not safety detail? See our best tongkat ali picks, ranked by disclosed standardization and testing →
Insomnia: the most-reported side effect
Across the human trials behind tongkat ali, insomnia is the side effect that comes up most often, particularly at higher doses or when it is taken later in the day. Reported alongside it, less often, are restlessness or irritability and a feeling of increased body temperature. Mild GI discomfort is reported too, and usually resolves by taking tongkat ali with food.
A 6-month double-blind, placebo-controlled trial reported no serious adverse events at 200mg per day, which is reassuring for short-to-medium-term use. The simplest way to reduce the insomnia risk is to take tongkat ali in the morning or early afternoon, not in the evening.
Heavy-metal contamination: a product-quality problem, not a pharmacology one
Tongkat ali root can accumulate heavy metals from soil, and testing surveys have found real problems in commercial products. One analysis found about 36% of tested products exceeded the mercury limit. A separate survey found about 26% noncompliant. This risk has nothing to do with whether the herb itself works or is safe at the intended dose — it is about what else ends up in the bottle.
This is why the hub's standardization guidance matters as much for safety as for potency. A product that discloses its eurycomanone percentage and backs it with independent lab testing, such as HPTLC verification, is addressing both problems at once: a vague "200:1 extract ratio" tells you nothing about active content, and untested products are exactly where contamination surveys found the failures.
If contamination concerns you, the testing is the safety lever
Nootropics Depot Tongkat Ali 2% Eurycomanone $0.32/day states its eurycomanone standardization on the label and is HPTLC-verified by an independent lab — the combination that addresses both the contamination risk and the under-standardization problem described above. Any product you choose should carry independent lab testing; that is the meaningful safety check for this category, not the brand name.
Who should avoid tongkat ali
- Hormone-sensitive cancers (prostate, breast): avoid, since tongkat ali may modulate testosterone.
- Pregnancy and breastfeeding: avoid — there is no safety data in these populations.
- Children and adolescents: not studied in developing individuals.
- On TRT or hormonal medication: talk to your endocrinologist first; interactions have not been ruled out.
Because long-term data beyond about 6 months is limited, some practitioners recommend using tongkat ali in defined courses rather than indefinitely, and including liver enzymes (ALT, AST) in routine bloodwork if you use it long-term. This is a precaution about limited data, not evidence of liver injury from tongkat ali itself.
What FDA adverse-event data shows — and its real limits
FDA adverse-event data (FAERS/CAERS) on tongkat ali is a very small dataset. It logs only 6 total reports naming tongkat ali, of which 4 (66.7%) were coded serious. Reported reactions include Urinary retention, Abdominal pain upper, Chills, Headache, Insomnia, among others — including insomnia, which lines up with what the trials themselves report as the most common complaint.
With only 6 reports on file, this database cannot tell you how common any of these reactions actually is. FAERS/CAERS is a voluntary, spontaneous reporting system with no denominator: no count of how many people took tongkat ali in the same period, and no requirement that anyone file a report at all. A report being filed doesn't mean tongkat ali caused the reaction. A few known limits of this data:
- Reports are voluntary — not all adverse events are reported
- No causal proof — a reported event does not mean the supplement caused it
- High-selling products naturally accumulate more reports (volume bias)
- Brand name matching is fuzzy — some reports may be misattributed or missed
FAERS/CAERS figures via the Verified Supplement Evidence Database, source: FDA CAERS (FAERS for Foods/Supplements).
Tongkat ali side effects at a glance
| Effect | How commonly reported per our sources | What reduces it | When it matters |
|---|---|---|---|
| Insomnia | The most-reported side effect in trials, especially at higher doses or taken late | Take in the morning or early afternoon; consider a lower dose | Always — the default tolerability issue |
| Restlessness / increased body temperature | Reported occasionally | Lower dose; take with food | If noticed, worth mentioning at your next check-up |
| GI discomfort | Rare | Take with food | Minor; usually resolves quickly |
| Heavy-metal (mercury) exposure | Documented in roughly a quarter to a third of tested commercial products — a product-quality issue, not an effect of the herb itself | Buy only third-party-tested products with a disclosed eurycomanone % | Always — independent of dose or how you feel |
Frequently asked questions
What are the most common tongkat ali side effects?
Insomnia is the side effect reported most often, especially at higher doses or when taken later in the day. Other reports include restlessness, a feeling of increased body temperature, and mild GI discomfort that usually resolves by taking it with food. A 6-month randomized trial reported no serious adverse events at 200mg per day. Taking tongkat ali in the morning is the simplest way to reduce the insomnia risk.
Is tongkat ali contaminated with heavy metals like mercury?
This is a documented, real problem, separate from anything the herb itself does pharmacologically. Surveys of commercial tongkat ali root have repeatedly found contamination: one analysis found about 36% of tested products exceeded the mercury limit, and a separate survey found about 26% noncompliant. Buy only third-party-tested products with a disclosed eurycomanone percentage. This is a product-quality issue you can screen for, not a reason to avoid the herb category entirely.
What does FDA adverse-event data show for tongkat ali?
FDA adverse-event data (FAERS/CAERS) logs only 6 total reports naming tongkat ali, 4 of them coded serious. The small number of reports on file means this data cannot tell you how common any reaction actually is. Reported reactions include urinary retention, abdominal pain upper, chills, headache, among others. FAERS is voluntary with no denominator, so these are raw counts, not a rate, and cannot be compared to other supplements.
Who should avoid tongkat ali or use extra caution?
Avoid tongkat ali if you have a hormone-sensitive condition, such as prostate or breast cancer, since it may modulate testosterone. It has not been studied in pregnancy or breastfeeding, so avoid it there too. If you take TRT or other hormonal medication, talk to your endocrinologist first, since interactions have not been ruled out. It also has not been studied in children or adolescents.
Related guides
- Tongkat Ali Dosage Guide — dose, standardization, and the heavy-metal warning in full
- Best Tongkat Ali Overall — every verified pick, ranked by disclosed standardization and testing
- Tongkat Ali vs Fadogia Agrestis — one has human evidence, one doesn't
- All Tongkat Ali Guides
Sources
- Leitão AE, et al. "A 6-month, double-blind, placebo-controlled, randomized trial to evaluate the effect of Eurycoma longifolia (Tongkat Ali) and concurrent training on erectile function and testosterone levels in androgen deficiency of aging males (ADAM)." Maturitas. 2021;145:78-85. PMID: 33541567
- Ang HH, et al. "Mercury contamination of tongkat ali products." Int J Toxicol. 2004. PMID: 15162849
- Ang HH, Lee KL. "Contamination of mercury in tongkat ali (Eurycoma longifolia) herbal preparations." Food Chem Toxicol. 2006. PMID: 16567029
- Li CH, et al. "Acute and 13-week subchronic toxicity of Eurycoma longifolia." Evid Based Complement Alternat Med. 2013. PMID: 24062779
- FDA CAERS (FAERS for Foods/Supplements) — tongkat ali category summary, via the site's Verified Supplement Evidence Database.